International Prospective Registry on Local Treatment Approaches in MLS

To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)

Age > 18 years
Biopsy proven MLS, including the reciprocal chromosomal translocation t(12;16)(q13;p11)
ECOG PS 0-2
Written informed consent to share coded information in this international Registry

Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04699292.

M D Anderson Cancer Center

Status: Active

Name Not Available

In order to confirm the promising results of the 36 Gy dose level in the DOREMY trial

(NCT02106312) and to compare outcome with other local treatment approaches.

Trial PhaseNo phase specified

Trial TypeNot provided by clinicaltrials.gov

Lead OrganizationThe Netherlands Cancer Institute

Description